Dr. Bellon on Ongoing Trials in Omitting Radiation in Breast Cancer Treatment

Jennifer Bellon, MD, radiation oncologist, Dana-Farber Cancer Institute, discusses some of the current ongoing trials looking at omitting radiation when it comes to the treatment of patients with breast cancer.

The LUMINA trial in Canada is evaluating the risk of local recurrence following breast-conserving surgery and endocrine therapy in low-risk Luminal A breast cancer.

The IDEA trial, which is being conducted at the University of Michigan, is using oncotype score to pick a favorable group of patients.

The PRECISION trial is using PAM50 to identify breast cancer patients with Luminal A disease that may be candidates for breast-conserving surgery without adjuvant radiotherapy.

However, despite these ongoing studies, the current standard of treatment for patients under 70 in this space still includes radiation therapy.